Manisa Celal Bayar University Mustafa Yardimci Education Family Health Center
Manisa, 45140, Turkey (Türkiye)
Location status: Recruiting
Location contact
Hüseyin Elbi
SUB_INVESTIGATOR
Sıdıka E. Yokuş
CONTACT
Sıdıka E. Yokuş
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07124832
The goal of this clinical trial is to evaluate the feasibility of using Socratic questioning as an alternative method for weight loss in adult patients with obesity (aged 18 to 65) in a primary care setting.
The main question it aims to answer is:
-Is Socratic questioning an effective alternative approach for promoting weight loss in patients with obesity?
Researchers will compare participants receiving Socratic questioning during follow-up visits with those receiving regular care to see if the intervention leads to greater weight loss.
Participants will:
* Complete a baseline questionnaire including 9 demographic questions and the 14-item Hospital Anxiety and Depression Scale (approx. 5 minutes). * Attend five in-person follow-up visits with their family physician over a 3-month period (every 15 or 30 days), where they will receive brief counseling (10-15 minutes per visit) and have their weight, height, and waist circumference measured. * Complete a 17-question final questionnaire at the end of 3 months (approx. 10-15 minutes). * Be referred to mental health services if necessary, based on initial screening results.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
Manisa, 45140, Turkey (Türkiye)
Location status: Recruiting
Hüseyin Elbi
SUB_INVESTIGATOR
Sıdıka E. Yokuş
CONTACT
Sıdıka E. Yokuş
PRINCIPAL_INVESTIGATOR
Work Packages:
Training will be delivered online by an instructor experienced in cognitive behavioral therapy.
During routine outpatient visits, physicians will assess patients diagnosed with obesity according to inclusion and exclusion criteria. Eligible patients will be recruited after providing informed consent. Patients will complete an information form and the Hospital Anxiety and Depression Scale (HADS). Those with significant psychopathology will be referred to a specialist for psychiatric evaluation. A first appointment (Day 0) will be scheduled.
After recruiting a patient, the physician will contact the research team to learn the patient's group assignment. The physician will be informed about the assigned group. Group allocation will be based on a pre-prepared list using computer-assisted block randomization.
The patient's assigned group will be recorded in the Family Medicine Information System, and a reminder note will be visible during each consultation.
The physician will take measurements and provide counseling about obesity. In the intervention group, the physician will apply the Socratic questioning technique. In the control group, the physician will follow routine obesity management practices. The next appointment (Day 15) will be scheduled.
The physician will provide counseling about obesity. No measurements will be taken at this visit. The next appointment (Day 30) will be scheduled.
The physician will provide counseling and take measurements. The next appointment (Day 60) will be scheduled.
The physician will provide counseling and take measurements. The next appointment (Day 90) will be scheduled.
Final measurements will be taken, and the study participation will be completed.
Physicians will share the collected data with the research team. The data from this pilot study will be analyzed.
At the end of the study, surveys including Likert-scale, multiple-choice, and open-ended questions will be administered to physicians and patients in the intervention group by the research team.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Socratic questioning is a method in which behaviour is examined through questions such as "what, where, which, who, when, how, and why". It consists of four stages: defining the problem, evaluating and identifying alternatives, redefining, and discussing feasible outcomes. Through this process, individuals develop their critical thinking skills and make self-evaluations.
Time frame: Baseline and 3 months
Body weight will be measured in kilograms using a calibrated digital scale. The outcome is the difference in percent change in body weight from baseline to 3 months between the Socratic questioning intervention group and the regular care control group.
Time frame: Baseline and 3 months
Body Mass Index will be measured in kg/m², calculated from weight (calibrated digital scale) and height (stadiometer). The outcome is the absolute change in BMI from baseline to 3 months.
Time frame: Baseline and 3 months
Waist circumference will be measured in centimeters using a non-elastic tape. The outcome is the absolute change in waist circumference (cm) from baseline to 3 months.
Time frame: Baseline and 3 months
Association between percentage weight loss from baseline to 3 months and self-reported previous weight loss attempts at baseline (yes/no).
Time frame: Baseline and 3 months
Correlation between percentage weight loss from baseline to 3 months and baseline willingness to create behavioral change score measured using a self-reported numerical rating scale (0-10, where 0=not willing at all and 10=extremely willing).
Contact information is provided by the study sponsor or research team.
Hüseyin Elbi
CONTACT
Sıdıka E. Yokuş
CONTACT
Sıdıka Ece Yokuş
Other
A Pragmatic Randomized Controlled Pilot Trial for Weight Loss in Patients With Obesity: Assessment of the Socratic Questioning Method
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06619041
Behavior, Body Weight
Aurora, Colorado, United States
View Trial DetailsNCT06858761
Body Weight, Nutrition Disorders
Bordeaux, France
View Trial DetailsNCT06374875
Body Weight, Digestive System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT06325722
Body Weight, Body Weight Changes
Bethesda, Maryland, United States
View Trial Details